Potential prophylactic treatments for COVID-19
N Ben-Zuk, ID Dechtman, I Henn, L Weiss, A Afriat… - Viruses, 2021 - mdpi.com
The World Health Organization declared the SARS-CoV-2 outbreak a Public Health
Emergency of International Concern at the end of January 2020 and a pandemic two months …
Emergency of International Concern at the end of January 2020 and a pandemic two months …
Anti COVID-19 drugs: need for more clinical evidence and global action
Abstract The World Health Organization (WHO) called the outbreak of coronavirus infectious
disease-2019 (COVID-19) a “Public Health Emergency of International Concern”(PHEIC) …
disease-2019 (COVID-19) a “Public Health Emergency of International Concern”(PHEIC) …
A scoping insight on potential prophylactics, vaccines and therapeutic weaponry for the ongoing novel coronavirus (COVID-19) pandemic-a comprehensive review
The emergence of highly virulent CoVs (SARS-CoV-2), the etiologic agent of novel ongoing
“COVID-19” pandemics has been marked as an alarming case of pneumonia posing a large …
“COVID-19” pandemics has been marked as an alarming case of pneumonia posing a large …
Drugs for the prevention and treatment of COVID-19 and its complications: An update on what we learned in the past 2 years
The COVID-19 Committee of the Lincei Academy has reviewed the scientific evidence
supporting the efficacy and safety of existing and new drugs/biologics for the preventing and …
supporting the efficacy and safety of existing and new drugs/biologics for the preventing and …
Safety perspectives on presently considered drugs for the treatment of COVID‐19
Intense efforts are underway to evaluate potential therapeutic agents for the treatment of
COVID‐19. In order to respond quickly to the crisis, the repurposing of existing drugs is the …
COVID‐19. In order to respond quickly to the crisis, the repurposing of existing drugs is the …
[HTML][HTML] Exploring pathophysiology of COVID-19 infection: faux espoir and dormant therapeutic options
V Nikhra - International Journal of Clinical Virology, 2020 - clinvirologyjournal.com
Conclusion: Confusion, despair and hopes: There is no vaccine for preexposure prophylaxis
or postexposure management. There are no specific approved drugs for the treatment for the …
or postexposure management. There are no specific approved drugs for the treatment for the …
An update on current therapeutic drugs treating COVID-19
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
[HTML][HTML] Natural history of COVID-19 and current knowledge on treatment therapeutic options
WG Dos Santos - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Despite intense research there is currently no effective vaccine available against the new
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged in the later 2019 …
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged in the later 2019 …
Use of antiviral agents and other therapies for COVID-19
MAT Blaskovich, AD Verderosa - Seminars in Respiratory and …, 2023 - thieme-connect.com
The coronavirus disease 2019 (COVID-19) pandemic led to a remarkably rapid
development of a range of effective prophylactic vaccines, including new technologies that …
development of a range of effective prophylactic vaccines, including new technologies that …
An overview on the treatments and prevention against COVID-19
Y Panahi, AM Gorabi, S Talaei, F Beiraghdar… - Virology Journal, 2023 - Springer
Background The coronavirus disease 2019 (COVID-19) caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to plague the world. While …
respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to plague the world. While …